# Treatment approaches for metastatic colorectal cancer
For metastatic colorectal cancer (colorectal cancer metastasis), a combination of different treatments is usually used. The choice depends on where the metastases are located, how well the body tolerates treatment, and what genetic properties the tumor cells have. The main treatment approaches are described below.
Chemotherapy
Chemotherapy is often the first step in metastatic colorectal cancer. The most commonly used regimens combine multiple drugs at once, such as fluorouracil with oxaliplatin (known under names such as Xeloda-oxaliplatin) or fluorouracil with irinotecan. These combinations work by disrupting the DNA synthesis of cancer cells so they can no longer divide.
ProveniIncluded in official guidelines, or approved by EMA or FDA
Chemotherapy is applied as a first treatment in virtually all patients with metastatic colorectal cancer. The side effects depend on which drugs are used, but can include nausea, diarrhea, fatigue and decreased white blood cells. With certain combinations, tingling in hands and feet can also occur, which may be temporary.
Targeted therapies against growth factors
For patients without certain genetic mutations (particularly RAS wild-type tumors), drugs that block growth signals are often given. A commonly used drug is bevacizumab, which inhibits blood vessel growth so the tumor receives less blood. Another type are EGFR inhibitors (cetuximab, panitumumab), which block growth signals to the tumor cells.
ProveniIncluded in official guidelines, or approved by EMA or FDA
These drugs are added to chemotherapy. Side effects of bevacizumab include elevated blood pressure and inflammatory reactions in the intestines. EGFR inhibitors can cause a characteristic skin rash and dry lips.
Immunotherapy
In recent years, immunotherapy has been used increasingly for metastatic colorectal cancer, especially when the tumor has certain genetic features (such as mismatch repair defects or high mutation burden). Drugs such as nivolumab, pembrolizumab and atezolizumab help the immune system better recognize and attack tumor cells.
ProveniIncluded in official guidelines, or approved by EMA or FDA
This treatment works by releasing checkpoints on immune cells. Side effects occur because the immune system reacts too strongly and attacks healthy tissue; this can manifest as inflammation of the lungs, intestines, skin or hormone glands.
Combinations of immunotherapy with chemotherapy or targeted drugs
Increasingly, immunotherapies are being combined with chemotherapy or targeted drugs for better results.
ProveniIncluded in official guidelines, or approved by EMA or FDA
These combinations are recommended in official treatment guidelines for certain tumor types. The side effects are the sum of those from both components.
Local treatment of liver metastases
When the cancer has mainly metastasized to the liver, local treatments can be considered alongside or instead of chemotherapy. This can be surgical removal of the metastases, but also radiofrequency ablation (where tumors are destroyed with heat) or chemoembolization (where chemotherapy is delivered directly into the blood vessels to the liver).
ProveniIncluded in official guidelines, or approved by EMA or FDA
Surgical removal of liver metastases is recommended in guidelines when this is technically feasible. The side effects depend on the procedure itself.
ResearchediPositive results in clinical studies, not yet standard treatment
Other local techniques such as radiofrequency ablation show positive results in studies and are being used increasingly often, but are not yet standard everywhere.
Radiotherapy
In patients with metastases in the pelvis (toward the intestines) or with local recurrence of the tumor, radiation therapy can help reduce pain and symptoms, or in some cases also to control limited recurrent disease.
ProveniIncluded in official guidelines, or approved by EMA or FDA
Radiotherapy is mainly used for symptom control. Side effects depend on the site of radiation and can include diarrhea, fatigue or skin reactions.
New targeted therapies
Research shows that certain genes in colorectal cancer cells can be used as targets. For example, drugs that target certain protein types (such as SLC7A5 transporters), or that target specific TP53 mutations, are being investigated in clinical trials.
ResearchediPositive results in clinical studies, not yet standard treatment
These drugs are not yet standard available and are only applied in study settings. They promise new perspective for patients for whom previous treatments no longer work.
Supportive care
Besides tumor control, care focused on symptom relief is essential. This can be combating fatigue (for example with guided movement), nutrition, psychological support and pain management. Early involvement of palliative care (focused on quality of life) can also help, especially as the disease progresses.
ProveniIncluded in official guidelines, or approved by EMA or FDA
Symptom management and psychosocial support are part of standard treatment and can significantly improve quality of life.
Surveillance and adjustments
Because colorectal cancer can change and sometimes lose sensitivity to certain drugs, regular checks are done on how treatment is working. If tumors grow despite treatment, medications are often switched or new combinations are tried. This adaptive approach is an important part of cancer care in metastatic disease.
ProveniIncluded in official guidelines, or approved by EMA or FDA
Regular monitoring and adjustment of treatment are part of standard care.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._